Drug Safety

CONTENTS

Statement of-

Apple, William S., Ph. D., executive director, American Pharmaceu-

tical Association; accompanied by Edward G. Feldmann, Ph. D.,

director, scientific division

Hussey, Hugh H., M.D., director, Division of Scientific Activities,

American Medical Association; accompanied by Paul R. M.

Donelan, attorney, legislative department..

Larrick, George P., Commissioner of Food and Drugs; accompanied
by Dr. Ralph Smith, William W. Goodrich, W. B. Rankin, and
M. D. Kinslow.
Smith, Austin, M.D., president, Pharmaceutical Manufacturers Asso-
ciation; accompanied by Leonard Scheele, M.D., senior vice presi-
dent, Warner-Lambert Pharmaceutical Co.; and Theodore G.
Klumpp, M.D., president, Winthrop Laboratories-

Smith, Austin, M.D., president, Pharmaceutical Manufacturers Asso-

ciation; accompanied by Theodore G. Klumpp, M.D., president,

Winthrop Laboratories; Leonard A. Scheele, M.D., senior vice

president, Warner-Lambert Pharmaceutical Co.; Karl H. Beyer,

M.D., vice president, Merck Sharp & Dohme Research Laborato-

ries; C. Joseph Statler, executive vice president and general counsel,

Pharmaceutical Manufacturers Association; and Karl Bambach,

Ph. D., senior vice president, Pharmaceutical Manufacturers Associ-

ation.

Letters, statements, etc., submitted for the record by-

Apple, William S., Ph. D., executive director, American Pharmaceu-

tical Association:

Excerpt from comment of Dr. Edward G. Feldman (exhibit 5). -

Excerpt from President Kennedy's message to the Congress re

proposed national mental health program, February 5, 1963-

Exhibit 1-Prescribing information, thorazine, brand of chlor-

promazine.--.

Exhibit 2-Press release from U.S. Public Health Service re drugs

for the treatment of schizophrenia, March 6, 1964.

Exhibit 3-Editorial by Don E. Francke, American Pharmaceu-

266

Exhibit 4-Statement on the pharmacy and therapeutics com-

251

mittee_

Exhibit 5-Editorial by Edward G. Feldmann, in Journal of

Pharmaceutical Sciences, February 1963__

Donelan, Paul R. M., attorney Legislative Department, American
Medical Association: Letter from F. J. L. Blasingame, M.D., exec-
utive vice president, American Medical Association, to Hon. L. H.
Fountain, July 13, 1964-

Dwyer, Hon. Florence P., a Representative in Congress from the

State of New Jersey: Excerpt from statement of William S. Apple,

Ph. D..

Fountain, Hon. L. H., a Representative in Congress from the State

241

Excerpt from statement of Austin Smith, M.D.